Original Article

Demographic Characteristics besides Clinical and Laboratory Manifestations of Children with Visceral Leishmaniasis in Rasht, Northern Iran


Background: Visceral leishmaniasis (Kala-azar) is an inherently dangerous and progressive disease that can be seen in many parts of the world, including Iran. Therefore, we decided to conduct this study on children with Kala-azar in Rasht-Iran.

Methods: In this descriptive study, the hospital records of all children with Kala-azar disease admitted to 17 Shahrivar Hospital, Rasht- Iran from 2009 to 2021 were reviewed. Required information were collected from patients' records and descriptive statistical analysis was done using SPSS version 24 statistical software.

Results: A total of 22 children with visceral leishmaniasis were admitted to 17 Shahrivar Hospital during the study period. The average age of the children was 2.93 ± 3.32 years. Most of them (59.1%) were boys and lived in the foothills (59.1%). The most common season for children to get the disease was spring (45.5%), and the average duration of the disease until hospitalization was 16.5 ± 13.54 days. In this study, the most common clinical manifestations included fever (90.9%), splenomegaly (77.3%), hepatomegaly (50%), weakness and restlessness (27.3%), and vomiting (18.2%). The most common laboratory findings were anemia (90.9%), leukopenia (59.1%), increased erythrocyte sedimentation rate (ESR) (75%), and increased C-reactive protein (CRP) (75%). 72.7% of the children were treated with liposomal amphotericin and others with glucantime, which were all successful.

Conclusion: The results of our studies were consistent with most studies in Iran and other countries. These findings can help in the diagnosis and management of children with Kala-azar and better control of the disease in the province.

1. World Health Organization. Control of the leishmaniases. World Health Organ Tech Rep Ser. 2010;(949):xii-xiii, 1-186, back cover. PMID: 21485694.
2. Shafiei R, Mohebali M, Akhoundi B, et al. Emergence of co-infection of visceral leishmaniasis in HIV-positive patients in northeast Iran: A preliminary study. Travel Med Infect Dis. 2014; 12 (2): 173- 8.
3. Alvar J, Vélez ID, Bern C, et al. Leishmaniasis worldwide and global estimates of its incidence. PLoS One. 2012; 7(5): e35671.
4. Mohebali M. Visceral leishmaniasis in Iran: review of the epidemiological and clinical features. Iran J Parasitol. 2013; 8 (3): 348-58.
5. Mohebali M, Hajjaran H, Hamzavi Y, et al. Epidemiological aspects of canine visceral leishmaniosis in the Islamic Republic of Iran. Vet Parasitol. 2005; 129(3- 4): 243- 51.
6. Rassi Y, Abai MR, Oshaghi MA, et al. First detection of Leishmania infantum in Phlebotomus kandelakii using molecular methods in north-eastern Islamic Republic of Iran. East Mediterr Health J. 2012 ;18(4):387-92.
7. Topno RK, Das VNR, Ranjan A, et al. Asymptomatic infection with visceral leishmaniasis in a disease- endemic area in Bihar, India. Am J Trop Med Hyg. 2010; 83 (3): 502-6.
8. Biglino A, Bolla C, Concialdi E, Trisciuoglio A, Romano A, Ferroglio E. Asymptomatic Leishmania infantum infection in an area of northwestern Italy (Piedmont region) where such infections are traditionally nonendemic. J Clin Microbiol. 2010; 48 (1): 131- 6.
9. Rafeey M, Jodeiry B. Visceral leishmaniasis in children. Yafte. 2005; 6 (4) :35-41.
10. Kadivar MR. Childhood visceral leishmaniasis complicated by bacterial infections. East Mediterr Health J. 2000; 6 (5- 6), 879- 883.
11. Shamsian SA, Fata A, Alinezhad R,et al. Clinical and Laboratory Findings of Visceral Leishmaniasis in Children Hospitalized in Mashhad, Northeastern Iran: A Twenty-Year Retrospective Study. Iran J Parasitol. 2020;15(4):495-499.
12. Nourian M, Heidari A, Tajali S, Ghasemi E, Mohebali M, Heidari A. Paediatric visceral leishmaniasis: a retrospective study on clinical manifestations, demographic features and laboratory findings of hospitalized cases in Iran between 2006 and 2016. Trop Doct. 2019; 49(1):59-61.
13. Minodier P, Piarroux R, Garnier J- M, Unal D, Perrimond H, Dumon H. Pediatric visceral leishmaniasis in southern France. Pediatr Infect Dis J. 1998; 17 (8): 701- 4.
14. Totan M, Dagdemir A, Muslu A, Albayrak D. Visceral childhood leishmaniasis in Turkey. Acta Paediatr. 2002; 91 (1): 62- 4.
15. Maltezou HC, Siafas C, Mavrikou M, et al. Visceral leishmaniasis during childhood in southern Greece. Clin Infect Dis. 2000; 31 (5): 1139- 43.
16. Choobineh H, Mamishi S, Bahonar A, Safdari R, Rezaeian M, Vaez Zadeh F. Clinical And Epidemiological Aspects Of Kala-Azar In Hospitalized Cases In Childrens Medical Center (1988-2004). Iran J Pediatr, 2005; 15 (4): 327-32.
17. Altaf C, Ahmed P, Ashraf T, Anwar M, Ahmed I. Clinicopathological features of childhood visceral leishmaniasis in Azad Jammu & Kashmir Pakistan. J Ayub Med Coll Abbottabad. 2005; 17 (4):48-50.
18. Singh K, Singh R, Parija SC, Faridi MMA, Bhatta N. Clinical and laboratory study of kala- azar in children in Nepal. J Trop Pediatr. 1999; 45 (2): 95- 7.
19. Tamook A, Ashenaei F, Yegane Moghadam J, Chinifroosh M, Amini Sani N, Habibzadeh Sh. Clinical and laboratory characteristics of children with kalazar in Ardabil province. Ardabil Univ Med Sci. 2006; 7 (1): 27-34.
20. Minodier P, Garnier JM. La leishmaniose viscérale infantile en Provence [Childhood visceral leishmaniasis in Provence]. Arch Pediatr. 2000 ;7 Suppl 3:572s-577s. French.
21. Grech V, Mizzi J, Mangion M, Vella C. Visceral leishmaniasis in Malta- an 18 year paediatric, population based study. Arch Dis Child. 2000; 82 (5): 381- 5.
22. Tiuman TS, Santos AO, Ueda-Nakamura T, Filho BP, Nakamura CV. Recent advances in leishmaniasis treatment. Int J Infect Dis. 2011;15(8):e525-32.
23. Roatt BM, de Oliveira Cardoso JM, De Brito RCF,et al. Recent advances and new strategies on leishmaniasis treatment. Appl Microbiol Biotechnol. 2020;104(21):8965-8977.
IssueVol 18 No 2 (2023) QRcode
SectionOriginal Article(s)
DOI https://doi.org/10.18502/ijpa.v18i2.13189
Child Diagnosis Epidemiology Kala azar Visceral leishmaniasis Iran

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
How to Cite
Hashemian H, Baghersalimi A, Asgharzadeh M, Mahdipour M. Demographic Characteristics besides Clinical and Laboratory Manifestations of Children with Visceral Leishmaniasis in Rasht, Northern Iran. Iran J Parasitol. 2023;18(2):229-236.